Enjoy complimentary customisation on priority with our Enterprise License!
The fertility services market is estimated to grow by USD 8.3 billion at a CAGR of 7.68% between 2022 and 2027. The rising prevalence of late parenthood, driven by social and economic factors, is increasing the demand for fertility treatments and services. The increase in fertility tourism, where individuals travel to other countries for fertility treatments, is expanding the market globally. Additionally, the rising number of fertility clinics, both locally and internationally, is providing more access to treatments and services, further driving market growth. Furthermore, advancements in treatments and technologies are increasing success rates, making fertility treatments more appealing to a wider audience. The growing acceptance and awareness of these issues are also reducing stigma, and encouraging more people to seek treatments.
To learn more about this report, Download Report Sample
This report extensively covers market segmentation by service (treatment services, testing and storage services, and others), end-user (fertility clinics, hospitals, surgical centers, and clinical research institutes), and geography (North America, Europe, APAC, Middle East and Africa, and South America). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
The market share growth by the treatment services segment will be significant during the forecast period. The treatment services segment is the highest revenue contributor to the market primarily due to the high cost of services and the prevalence of diseases such as diabetes and obesity in both men and women that adversely impact their fertility and impair the functions of their reproductive organs.
Get a glance at the market contribution of various segments Request a PDF Sample
The treatment services segment was valued at USD 5.83 billion in 2017. There is also an increase in awareness among women in semi-urban areas, predominantly in developed countries, thereby leading to the gradual adoption of these treatments. However, the affordability of the procedure is a major impediment in rural areas. Thus, an increase in such initiatives, convenience, improving the education system, and growing disposable incomes are likely to drive the market for treatment services and, in turn, support the growth of the market.
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to contribute 31% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The market share of North America is high due to the presence of a well-established healthcare system that provides high-quality services, primarily through clinics and hospitals. Rising investment in the healthcare sector in the US also contributes to the high market share. The US is the dominating country in the region and acts as the major revenue generator, followed by Canada. Huge investment in the pharmaceutical industry and the presence of many pharmaceutical giants are major factors backing up the dominance of the US in the region and even globally.
The market is influenced by various factors such as alcohol and drug use, stress levels, smoking, and obesity, which can impact this in both men and women. Environmental factors and lifestyle choices play a significant role in fertility rates, affecting sperm counts, sperm morphology, and motility. For individuals facing challenges, treatments like In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) are available, especially important for the LGBT community and those beyond childbearing age. Access to these services is supported by regulatory frameworks and the presence of specialized healthcare facilities. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The rising prevalence of late parenthood is the key factor driving the market growth. The increasing age of parenthood is a significant factor contributing to issues, particularly impacting European countries and some Asian nations like Japan. This trend towards later motherhood goes against the natural fertility window for women, which is typically highest in their mid-20s, starting to decline in their early 30s and decreasing further after 35 years.
Advanced age reduces the likelihood of pregnancy and increases the risk of complications such as gestational diabetes, high blood pressure, and larger babies. Factors such as alcohol and drug use, stress levels, smoking, obesity, and environmental factors can also affect fertility and pregnancy outcomes. Consequently, the rising prevalence of delayed parenthood is expected to increase the demand for these services such as various treatment options (ICSI, zygote intrafallopian transfer, gamete intrafallopian transfer, IVF), as well as testing and storage services, benefiting the market in the forecast period.
The rising number of sperm donors at sperm banks is the primary trend in the market growth. There has been a rise in the number of sperm donors in the recent past because of the rise in the number of donors for money. The amount paid to donors is attracting more donors each year. The sperm specimen given by an anonymous donor is used for insemination purposes and injected into the uterus using a syringe to achieve pregnancy. This process can be conducted at hospitals, clinics, and also at home with varying degrees of success.
The rising number of donors at sperm banks gives the service providers access to a larger pool of semen samples used for treatment. As these treatments usually require more than one sample per patient, it provides a larger scope for revenue generation to service providers in the market. Thus, the rise in the number of donors will lead to an increase in the use of these services and several treatments such as artificial insemination, gamete intrafallopian transfer, and IVF, thus boosting their sales in the future.
The high complication rate in fertility services is a major challenge to market growth. The treatments can cause various complications, including multiple pregnancies, ovarian hyperstimulation syndrome, internal bleeding or infection, premature delivery, the birth of low-weight babies, and congenital defects. Complications related to male fertility services are rare but can occur in people undergoing surgeries. These complications include infections, bruising, bleeding, and limited efficacy of services.
Allergic reactions to anesthesia are also potential side effects of these treatments. Antibiotics and other medications can cause diarrhea in some people. Gonadotropins may cause hot flushes, breast tenderness, swelling, abdominal pain, bloating, and menopause-type symptoms. These complications of these treatment services and medications limit their use and can lead away from the prospective client base due to the fear of side effects or adverse outcomes of procedures. Such factors will hinder market growth during the forecast period.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Apollo Hospitals - The company offers fertility services such as infertility treatment.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
The market is driven by various factors, including technological advancements and increasing awareness of infertility treatments. As the market embraces artificial intelligence (AI) and robotics in diagnostic procedures and treatments, it offers new hope to couples facing these issues. The market also sees growth due to the rising prevalence of delayed pregnancies in women and lifestyle alterations impacting fertility. The market is influenced by various factors such as changing market regulations and advancements in assisted reproductive technology (ART) like intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF). It caters to both developed and emerging nations, offering solutions for female infertility, male infertility, and LGBTQ+ family building. The market addresses challenges like hormonal imbalance and genetic disorders, providing services such as fertility testing and fertility preservation. With a focus on human-centered care (HCC) and flexible coverage options, it strives to make treatments more accessible despite the high cost associated with fertility therapy.
The market is also influenced by various factors, including changes in market regulations and the high cost of therapy. It caters to individuals in both developed nations and emerging revenue pockets, offering a range of services such as assisted reproductive technology (ART) procedures like intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF). The market addresses issues like female infertility caused by conditions such as polycystic ovarian syndrome (PCOS) and endometrial tuberculosis, as well as male infertility due to factors like low sperm count and poor sperm morphology. With advancements in laboratory techniques and technical developments like robots for sperm motility assessment, the market aims to optimize the value chain and improve treatment outcomes.
The market is a complex landscape influenced by various factors such as healthcare and research spending and trade regulations. It encompasses a range of services and treatments, including assisted reproductive technology (ART) like in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Issues like infertility-causing medical illnesses and poor sperm motility are addressed through advanced techniques like preimplantation genetic testing and robotics. Health insurance providers and reimbursement policies play a crucial role in making these services accessible to a wider population. Public knowledge and awareness, along with the optimization of the value chain, are key drivers in advancing the field of fertility services.
Market Scope |
|
Report Coverage |
Details |
Page number |
168 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.68% |
Market growth 2023-2027 |
USD 8.3 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
6.31 |
Regional analysis |
North America, Europe, APAC, Middle East and Africa, and South America |
Performing market contribution |
North America at 31% |
Key countries |
US, China, India, UK, and Germany |
Competitive landscape |
Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Anecova SA, Apollo Hospitals Enterprise Ltd., CARE Fertility Group Ltd., Carolinas Fertility Institute, Cryolab Ltd., Genea Ltd., Instituto Bernabeu SL, Instituto Valenciano de Infertilidad, Kids Clinic India Private Ltd, Lucile Packard Childrens Hospital, Medicover AB, Merck KGaA, Monash IVF Group, Nova IVF Fertility Private Ltd, The Cooper Companies Inc., The Johns Hopkins Health System Corp., University of Pennsylvania Health System, Virtus Health Ltd, Vitrolife AB, and Xytex Corp. |
Market dynamics |
Parent market analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.